Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. GlobalData uses proprietary data and analytics to provide a comprehensive report on the implantable cardioverter defibrillators devices market, including market shares of different players within Italy. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the implantable cardioverter defibrillators market in Italy was Medtronic followed by Biotronik SE, Abbott Laboratories and Boston Scientific.
ICDs contain three main components: a pulse generator, electrodes, and leads. However, the devices can also be leadless. Single Chamber ICD, Dual Chamber ICD and Subcutaneous ICD are tracked under this segment. A single chamber ICD attaches to one chamber of the heart i.e. , right ventricle, and monitors the electrical activity of that chamber. A dual chamber ICD monitors the electrical activity in two chambers of the heart (an atrium and a ventricle) and delivers electric pulses to one or both chambers in the event of an arrhythmia. The subcutaneous ICD (S-ICD) also known as leadless ICDs consists of an electrode and a pulse generator which functions without the placement of the electrical wires (leads) in the heart.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the implantable cardioverter defibrillators devices market within Italy was expected to be over $100m in 2022.
For the latest complete market share analysis of implantable cardioverter defibrillators device market in Italy, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
